Arrowstreet Capital, Limited Partnership Ptc Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $827,330 - $1.22 Million	-17,678 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $847,836 - $1.2 Million	17,678 New	17,678 $1.08 Million
Q3 2020 Nov 12, 2020	SELL	$45.41 - $57.07 $3.74 Million - $4.7 Million	-82,400 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$42.56 - $54.98 $3.51 Million - $4.53 Million	82,400 New	82,400 $4.18 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $5.02 Million - $9.2 Million	-154,969 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $4.99 Million - $7.76 Million	154,969 New	154,969 $7.44 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $1.23 Million - $1.57 Million	-34,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $977,532 - $1.37 Million	34,800 New	34,800 $1.31 Million
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $414,054 - $583,462	-12,214 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $326,595 - $608,459	-12,708 Reduced 50.99%	12,214 $412,000
Q1 2018 May 14, 2018	BUY	$17.46 - $32.59 $435,138 - $812,207	24,922 New	24,922 $674,000

228

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.53B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.